Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Loxo Oncology CS (LOXO)

Loxo Oncology CS (LOXO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,182,943
  • Shares Outstanding, K 30,615
  • Annual Sales, $ 21,300 K
  • Annual Income, $ -148,880 K
  • 60-Month Beta 2.51
  • Price/Sales 48.88
  • Price/Cash Flow N/A
  • Price/Book 18.85
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.09
  • Most Recent Earnings -0.89 on 11/08/18
  • Next Earnings Date 03/07/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -1.16
  • Number of Estimates 8
  • High Estimate -0.56
  • Low Estimate -2.47
  • Prior Year -0.69
  • Growth Rate Est. (year over year) -68.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
233.14 +0.71%
on 01/16/19
234.93 -0.06%
on 02/13/19
+1.13 (+0.48%)
since 01/15/19
3-Month
125.00 +87.84%
on 12/24/18
234.93 -0.06%
on 02/13/19
+83.27 (+54.95%)
since 11/15/18
52-Week
103.50 +126.86%
on 02/20/18
234.93 -0.06%
on 02/13/19
+129.83 (+123.68%)
since 02/15/18

Most Recent Stories

More News
1.0% Return Seen to Date on SmarTrend Loxo Oncology In Call (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on January 7th, 2019 at $232.41. In approximately 19 months, Loxo Oncology In has returned 0.97% as of today's recent price of $234.66....

LOXO : 234.80 (+0.06%)
Loxo Oncology In Shares Up 1.0% Since SmarTrend's Buy Recommendation (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on January 7th, 2019 at $232.41. In approximately 19 months, Loxo Oncology In has returned 0.97% as of today's recent price of $234.66....

LOXO : 234.80 (+0.06%)
Global Pontine Glioma Drug Market 2020 Comprehensive Industry and Vendor Landscape 2025

features an intrinsic study of the current status of this market and detailed insights and deep research on some of the major and unique aspects of the market. The report offers an accurate prediction...

BZYR : 0.0160 (unch)
LOXO : 234.80 (+0.06%)
MDNA.TO : 5.78 (+5.67%)
MDVN : 81.48 (+0.05%)
Loxo Oncology In Up 1.0% Since SmarTrend Uptrend Call (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on January 7th, 2019 at $232.41. In approximately 18 months, Loxo Oncology In has returned 0.97% as of today's recent price of $234.66....

LOXO : 234.80 (+0.06%)
1.0% Return Seen to Date on SmarTrend Loxo Oncology In Call (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on January 7th, 2019 at $232.41. In approximately 17 months, Loxo Oncology In has returned 0.97% as of today's recent price of $234.66....

LOXO : 234.80 (+0.06%)
Uptrend Call Working As Loxo Oncology In Stock Rises 1.0% (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on January 7th, 2019 at $232.41. In approximately 17 months, Loxo Oncology In has returned 0.97% as of today's recent price of $234.66....

LOXO : 234.80 (+0.06%)
1.0% Return Seen to Date on SmarTrend Loxo Oncology In Call (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on January 7th, 2019 at $232.41. In approximately 17 months, Loxo Oncology In has returned 0.97% as of today's recent price of $234.66....

LOXO : 234.80 (+0.06%)
Loxo Oncology In Up 1.0% Since SmarTrend Uptrend Call (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on January 7th, 2019 at $232.41. In approximately 17 months, Loxo Oncology In has returned 0.97% as of today's recent price of $234.66....

LOXO : 234.80 (+0.06%)
1.0% Return Seen to Date on SmarTrend Loxo Oncology In Call (LOXO)

SmarTrend identified an Uptrend for Loxo Oncology In (NASDAQ:LOXO) on January 7th, 2019 at $232.41. In approximately 16 months, Loxo Oncology In has returned 0.97% as of today's recent price of $234.66....

LOXO : 234.80 (+0.06%)
Pontine Glioma Drug Market 2020 Ongoing Trends and Recent Developments | Arog Pharmaceuticals, Inc., Burzynski Research Institute, Inc., Loxo Oncology, etc

MENAFN07052020007010647ID1100130845

BZYR : 0.0160 (unch)
LOXO : 234.80 (+0.06%)
MDNA.TO : 5.78 (+5.67%)
MDVN : 81.48 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade LOXO with:

Business Summary

Loxo Oncology, Inc. is a biopharmaceutical company. It develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Loxo Oncology, Inc. is headquartered in Stamford, Connecticut.

See More

Key Turning Points

2nd Resistance Point 234.95
1st Resistance Point 234.81
Last Price 234.80
1st Support Level 234.59
2nd Support Level 234.51

See More

52-Week High 234.93
Last Price 234.80
Fibonacci 61.8% 184.72
Fibonacci 50% 169.21
Fibonacci 38.2% 153.71
52-Week Low 103.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar